NXGEF News 0.3410 Nexgen (NXGEF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nexgen (NXGEF) 0.3410 $NXGEF

NexGen Drills Best Hole to Date at Arrow-RK-14-30 Intersects Numerous Zones of Mineralization Totalling 47.2 Meters
Marketwire - Mon Mar 31, 5:31AM CDT
Highlights

TAD Encounters Multiple Conductive Anomalies on the Hydrothermal Graphite Prospect in Ontario
Marketwire - Thu Mar 20, 2:21AM CDT
TAD Mineral Exploration Inc. ("TAD" or the "Company" (OTCBB: TADMF)(TSX VENTURE: TJ) is pleased to announce, that the Company has encountered multiple strong conductive TDEM anomalies on its Hydrothermal Graphite prospect in Ontario. These anomalies were outlined by the airborne survey recently completed by Prospectair Geosurveys Inc.

NexGen Extends Arrow Discovery Zone. Second Hole Intersects Several Highly Anomalous Radioactive Zones, Rook I West, SW Athabasca Basin
Marketwire - Thu Mar 13, 5:31AM CDT
Highlights

Lucky Strike Resources Ltd.: Western Athabasca Syndicate Receives Drill Permits for the Preston Lake Uranium Project in SW Athabasca Basin, Saskatchewan
Marketwire - Thu Feb 27, 9:01AM CST
Lucky Strike Resources Ltd. (TSX VENTURE: LKY) ("Lucky" is pleased to announce the Western Athabasca Syndicate has received drill permits for its flagship Preston Lake Uranium Property (the "Property". The diamond drill program is slated to commence in the second week of March and will test several highly prospective targets identified by the extensive 2013-2014 fieldwork.

Western Athabasca Syndicate Receives Drill Permits for the Preston Lake Uranium Project in SW Athabasca Basin, Saskatchewan
Marketwire - Thu Feb 27, 7:05AM CST
Skyharbour Resources Ltd. (TSX VENTURE:SYH)(PINKSHEETS:SYHBF) ("Skyharbour" is pleased to announce the Western Athabasca Syndicate has received drill permits for its flagship Preston Lake Uranium Property (the "Property". The diamond drill program is slated to commence in the second week of March and will test several highly prospective targets identified by the extensive 2013-2014 fieldwork.

NexGen Energy Ltd.: Radio Option Agreement Extension Close
Marketwire - Wed Feb 26, 5:27PM CST
NexGen Energy Ltd. (TSX VENTURE: NXE) ("NexGen" or the "Company" is pleased to announce that further to its news release on January 16, 2014, and pursuant to the letter agreement dated January 15, 2014 (the "Letter Agreement" entered into with Michael Lederhouse, Timothy A. Young and Matthew A. Mason (collectively, the "Optionors", the Company has issued an aggregate 5,714,286 units (the "Units" to the Optionors, with each Unit comprising one common share in the capital of the Company and one common share purchase warrant with an exercise price of C$0.50 per common share, expiring May 31, 2017. Pursuant to the Letter Agreement, and in consideration for the issuance of the Units, the Optionors have amended the Radio option agreement dated December 5, 2011, as amended (the "the Option Agreement".

NexGen Energy Completes First Hole at Arrow Prospect; Intersects Additional Zones of Highly Anomalous Radioactivity, Rook I West, SW Athabasca Basin
Marketwire - Mon Feb 24, 5:02AM CST
NexGen Energy Ltd. (TSX VENTURE: NXE) ("NexGen" or the "Company" is pleased to announce the discovery of further new zones of uranium mineralisation within the first hole in the Arrow prospect, Rook 1 project in the SW Athabasca Basin.

NexGen Drills 26.2 Meters of Highly Anomalous Radioactivity on First Hole at Arrow, Rook I, SW Athabasca Basin Highlights
Marketwire - Wed Feb 19, 8:55AM CST
NexGen Energy Ltd. (TSX VENTURE: NXE) ("NexGen" or the "Company" is pleased to announce the discovery of a new zone of uranium mineralisation in the Rook 1 project in the SW Athabasca Basin.

NexGen Commences 6,000-Meter Winter Drilling Program at Rook I Project, Western Athabasca Basin, Saskatchewan
Marketwire - Mon Jan 20, 5:31AM CST
NexGen Energy Ltd. (TSX VENTURE: NXE) ("NexGen" or the "Company" is pleased to announce that it has commenced a two drill, 6,000 meter program on the Rook I project. The Rook I project is immediately adjacent to, and on trend, northeast from Fission Uranium's high-grade uranium discovery, Patterson Lake South ("PLS" project.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading